These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

380 related items for PubMed ID: 8638193

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Medical management of patients with difficult-to-treat inflammatory bowel disease.
    van Hogezand RA.
    Neth J Med; 1994 Aug; 45(2):55-9. PubMed ID: 7936006
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Birth outcome in women with ulcerative colitis and Crohn's disease, and pharmacoepidemiological aspects of anti-inflammatory drug therapy.
    Nørgård BM.
    Dan Med Bull; 2011 Dec; 58(12):B4360. PubMed ID: 22142578
    [Abstract] [Full Text] [Related]

  • 5. Advances in drug therapy for inflammatory bowel disease.
    Peppercorn MA.
    Ann Intern Med; 1990 Jan 01; 112(1):50-60. PubMed ID: 2152845
    [Abstract] [Full Text] [Related]

  • 6. [Chronic inflammatory bowel diseases].
    Herrlinger K, Stange EF.
    Dtsch Med Wochenschr; 2004 Oct 15; 129(42):2241-50; quiz 2251-4. PubMed ID: 15529447
    [No Abstract] [Full Text] [Related]

  • 7. A practical guide to the management of distal ulcerative colitis.
    Ardizzone S, Bianchi Porro G.
    Drugs; 1998 Apr 15; 55(4):519-42. PubMed ID: 9561342
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Comparative tolerability of treatments for inflammatory bowel disease.
    Stein RB, Hanauer SB.
    Drug Saf; 2000 Nov 15; 23(5):429-48. PubMed ID: 11085348
    [Abstract] [Full Text] [Related]

  • 10. Risk-benefit assessment of drugs used in the treatment of inflammatory bowel disease.
    Hanauer SB, Stathopoulos G.
    Drug Saf; 1991 Nov 15; 6(3):192-219. PubMed ID: 1676590
    [Abstract] [Full Text] [Related]

  • 11. Newer treatments for inflammatory bowel disease.
    Stotland BR, Lichtenstein GR.
    Prim Care; 1996 Sep 15; 23(3):577-608. PubMed ID: 8888346
    [Abstract] [Full Text] [Related]

  • 12. Inflammatory bowel disease.
    Van Rosendaal GM.
    CMAJ; 1989 Jul 15; 141(2):113-23; discussion 123-4. PubMed ID: 2568163
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. [Indications for immunosuppressive therapy of chronic inflammatory bowel diseases].
    Schölmerich J.
    Internist (Berl); 1997 Jun 15; 38(6):582-9. PubMed ID: 9265003
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. 5-aminosalicylates in inflammatory bowel disease--the more the merrier?
    Forbes A.
    Eur J Gastroenterol Hepatol; 1995 Nov 15; 7(11):1017-9. PubMed ID: 8680898
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Drug therapy of inflammatory bowel disease.
    Sack DM, Peppercorn MA.
    Pharmacotherapy; 1983 Nov 15; 3(3):158-76. PubMed ID: 6136027
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 19.